Most GLOW research products are sold pre-blended with a 5:1:1 ratio (50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157)
Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats
This may contribute to its documented ability to counteract vessel occlusion by rapidly activating collateral bypass pathways
Drug Design, Development and Therapy, 16, 41934204
Research protocols commonly include: Daily zinc supplementation Daily vitamin C supplementation alongside GHK-Cu-containing formulations
BPC-157 promotes the growth of new cells and supports the formation of small blood vessels, supplying oxygen and nutrients to an injured tissue when the gut lining is damaged by ulcers, inflammation, or stress